✦ LIBER ✦

PDB4 HbA1C Reduction Associated With Initial Versus Sequential Combination Therapy With Pioglitazone (PIO) and Dipeptidyl Peptidase-4 Inhibitors (DPP4i) in Patients With Type 2 Diabetes Mellitus (T2DM)

✍ Scribed by Bron, M.; Chen, K.; Ayyagari, R.; Sharma, H.; Wu, E.Q.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PDB17 Comparison of Clinical and Economi

✍ Bron, M.; Chen, K.; Cheng, D.; Bensimon, A.G.; Wu, E.Q. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

Effect of initial combination therapy wi

✍ K. H. Yoon; G. R. Shockey; R. Teng; G. T. Golm; P. R. Thakkar; A. G. Meehan; D. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 179 KB

Canagliflozin (CANA) Added on to Dipepti

✍ Woo, Vincent; Wysham, Carol; Mathieu, Chantal; Desai, Mehul; Alba, Maria; Capuan 📂 Article 📅 2013 🏛 Canadian Diabetes Association 🌐 English ⚖ 53 KB

Efficacy and safety of dipeptidyl peptid

✍ Wu, D.; Li, L.; Liu, C. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 673 KB